Should the health community promote smokeless tobacco (Snus) as a harm reduction measure?

PLoS Medicine

Volumn 4, Issue 7, 2007, Pages 1138-1141

  Gartner, Coral E ^a   Hall, Wayne D ^a   Chapman, Simon ^b   Freeman, Becky ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

CIGARETTE SMOKING; HARM REDUCTION; HUMAN; JUVENILE; NICOTINE REPLACEMENT THERAPY; PREVALENCE; PUBLIC HEALTH; REVIEW; SMOKELESS TOBACCO; SMOKING; SNUS; SWEDEN; TOBACCO DEPENDENCE; TOBACCO INDUSTRY; ADVERTIZING; ARTICLE; HEALTH CARE POLICY; PUBLIC OPINION; RISK ASSESSMENT; STANDARD;

ADVERTISING AS TOPIC; HARM REDUCTION; HEALTH POLICY; HUMANS; PUBLIC HEALTH; PUBLIC OPINION; RISK ASSESSMENT; SWEDEN; TOBACCO INDUSTRY; TOBACCO, SMOKELESS;

EID: 34547565089     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040185     Document Type: Review

References (30)

1. Chaloupka FJ, Wakefield M, Czart C (2001) Taxing tobacco: The impact of tobacco taxes on cigarette smoking and other tobacco use. In: Rabin RL, Sugarman SD, editors. Regulating tobacco. Oxford: Oxford University Press. pp. 39-71.
2. World Health Organization (1998) Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization.
3. Stratton K, Shetty P, Wallace R, Bondurant S, editors (2001) Clearing the smoke: Assessing the science base for tobacco harm reduction. Washington (D. C.): National Academy Press. Available: http://www.nap.edu/catalog/10029.html. Accessed 31 May 2007.
4. Shiffman S, Gitchell JG, Warner KE, Slade J, Henningfield JE, et al. (2002) Tobacco harm reduction: Conceptual structure and nomenclature for analysis and research. Nicotine Tob Res 4: S113-S129.
5. Critchley JA, Unal B (2003) Health effects associated with smokeless tobacco: A systematic review. Thorax 58: 435-443.
6. Winn DM (1997) Epidemiology of cancer and other systemic effects associated with the use of smokeless tobacco. Adv Dent Res 11: 313-321.
7. Luo J, Ye W, Zendehdel K, Adami J, Adami HO, et al. (2007) Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: A retrospective cohort study. Lancet. E-pub 9 May 2007.
8. Foulds J, Ramström L, Burke M, Fagerström K (2003) Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 12: 349-359.
9. Ramstrom LM (2000) Snuff - An alternative nicotine delivery system. In: Ferrence R, Slade J, Room R, Pope M, editors. Nicotine and public health. Washington (D. C.): American Public Health Association. pp. 159-178.
10. Asplund K (2003) Smokeless tobacco and cardiovascular disease. Prog Cardiovasc Dis 45: 383-394.
11. Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, et al. (2007) Assessment of Swedish snus for tobacco harm reduction: An epidemiological modelling study. Lancet. E-pub 9 May 2007.
12. Furberg H, Lichtenstein P, Pedersen NL, Bulik C, Sullivan PF (2006) Cigarettes and oral snuff use in Sweden: Prevalence and transitions. Addiction 101: 1509-1515.
13. Ramström LM, Foulds J (2006) Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 15: 210-214.
14. Peto R, Lopez A, Boreham J, Thun M (2006) Mortality from smoking in developed countries 1950-2000 [updated June 2006]. 2nd edition. Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, Medical Sciences Division, Oxford University. Available: http://www.ctsu.ox.ac.uk/~tobacco/. Accessed 31 May 2007.
15. Kozlowski LT (2002) Harm reduction, public health, and human rights: Smokers have a right to be informed of significant harm reduction options. Nicotine Tob Res 4: S55-S60.
16. Phillips CV, Wang C, Guenzel B (2005) You might as well smoke: The misleading and harmful public message about smokeless tobacco. BMC Public Health 5: 31.
17. Waterbor JW, Adams RM, Robinson JM, Crabtree FG, Accortt NA, et al. (2004) Disparities between public health educational materials and the scientific evidence that smokeless tobacco use causes cancer. J Cancer Educ 19: 17-28.
18. Furberg H, Bulik CM, Lerman C, Lichtenstein P, Pedersen NL, et al. (2005) Is Swedish snus associated with smoking initiation or smoking cessation? Tob Control 14: 422-424.
19. Gilljam H, Galanti MR (2003) Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden. Addiction 98: 1183-1189.
20. Morgan Stanley Research (2006) UST: further from the precipice, but still significant L-T issues.
21. World Health Organization (2005) WHO framework convention on tobacco control. Geneva: WHO. Available: http://www.who.int/tobacco/framework/download/ en/index.html. Accessed 31 May 2007.
22. Fichtenberg CM, Glantz SA (2002) Effect of smoke-free workplaces on smoking behaviour: Systematic review. BMJ 325: 188.
23. Warner KE, Burns DM (2003) Hardening and the hard-core smoker: Concepts, evidence, and implications. Nicotine Tob Res 5: 37-48.
24. Morley KI, Hall WD, Hausdorf K, Owen N (2006) "Occasional" and "social" smokers: Potential target groups for smoking cessation campaigns? Aust N Z J Public Health 30: 550-554.
25. Health Canada Tobacco Control Programme (2007) Canadian tobacco use monitoring survey (CTUMS) 2006. Ottawa: Health Canada. Available: http://www.hc-sc.gc.ca/hl-vs/tobac-tabac/research-recherche/stat/ctums-esutc/ 2006/index_e.html. Accessed 31 May 2007.
26. White V, Hayman J (2006) Smoking behaviours of Australian secondary students 2005. Melbourne: The Centre for Behavioural Research in Cancer at The Cancer Council Victoria. Available:http://www.nationaldrugstrategy.gov.au/ internet/drugstrategy/publishing.nsf/Content/E1B70590AD4EF56DCA257225000EDCE9/ $File/mono59.pdf. Accessed 31 May 2007.
27. Cummings KM, Hyland A (2005) Impact of nicotine replacement therapy on smoking behavior. Annu Rev Public Health 26: 583-599.
28. Hatsukami D, Mooney M, Murphy S, Lesage M, Babb D, et al. (2007) Effects of high dose transdermal nicotine replacement in cigarette smokers. Pharmacol Biochem Behav 86: 132-139.
29. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, et al. (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111: 81-90.
30. Action on Smoking and Health Australia (1995) Tobacco in Australia: Facts and issues. Available: http://www.quit.org.au/quit/fandi/welcome.htm. Accessed 31 May 2007.